EPHB6 and cancer: We also observed EPHB6 mutation-induced paclitaxel resistance in A375P melanoma and Huh7 liver cancer cells (Supplementary Fig. 2B, C and Fig. 1c, d), which may indicate EPHB6 (Q926R) mutation-induced paclitaxel resistance in diverse cancer types.